Premium
Does the Best Practice Tariff for paediatric diabetes create inequity of service provision and the death knell for any semblance of a UK‐wide NHS?
Author(s) -
Lowes Lesley,
Robertson Kenneth,
Lamb Bill,
Chaney David
Publication year - 2013
Publication title -
practical diabetes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.205
H-Index - 24
eISSN - 2047-2900
pISSN - 2047-2897
DOI - 10.1002/pdi.1800
Subject(s) - medicine , excellence , nice , tariff , national service framework , equity (law) , best practice , diabetes mellitus , family medicine , diabetology , audit , type 2 diabetes , pediatrics , psychiatry , business , accounting , political science , mental health , law , endocrinology , computer science , programming language
conditions in childhood. In the United Kingdom (UK), there are about 26 500 children and young people with type 1 diabetes.1 Paediatric diabetes outcomes in the UK are poor when compared to the rest of Europe, and are not improving. The data are extremely concerning – although the recommendation from the National Institute for Health and Care Excellence (NICE) is a glycosylated haemoglobin (HbA1c) target of 58mmol/mol (7.5%) or less,2 the mean HbA1c between 2003–2010 for children aged <18 years in England and Wales was 72mmol/mol (8.7%).3 No such national figure is available for Scotland but there is no reason to believe that it would be much different.